Skip to content

Effects of ischemic remote conditioning on clinical outcomes in patients with coronary heart disease

Effects of ischemic remote conditioning on clinical outcomes in patients with coronary heart disease - Effects of ischemic remote conditioning on clinical outcomes

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006460
Enrollment
500
Registered
2011-10-03
Start date
2011-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with heart failure or ischemic heart disease

Interventions

Intervention group: remote ischemic conditioning + standardized treatment. Method: Intermittent arm ischaemia through four cycles of 5-minuites infl ation and 5-minuites defl ation of a blood-pressu

Sponsors

University of Yamanashi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted to University of Yamanashi Hospital and fulfilled with following inclusion criteria. (1) Age; 20 years and older. (2) Male and female. (3) Heartfailure or ischemic heart disease.

Exclusion criteria

Exclusion criteria: Patients are excluded with following exclusion criteria. (1) Patients on Hemodialysis therapy and with blood access on upper arm. (2) Patients with severe complications and malignancy. (3) Patients with decreased blood flow or trauma on upper arm.

Design outcomes

Primary

MeasureTime frame
All enrolled patients are prospectively followed up for 5 years or until the occurrence of cardiac events. Cardiac events include cardiac death, hospitalization with heart failure, arrhythmia, non-fatal myocardial infarction, unstable angina required coronary revascularization.

Secondary

MeasureTime frame
Endothelial function of brachial artery (FMD), intima-media thickness (IMT) of carotid arteries, %fractional shortning and %ejection fraction measured by cardiac ultrsaound are evaluated at the enrollment, 1 week, and 1 months after enrollment. Blood sampling are preformed at the enrollment, 1 week and 1 month after enrollment for measurement of inflammatory markers, and angiogenic factors.

Countries

Japan

Contacts

Public ContactTakamitsu Nakamura

University of Yamanashi Internal medicine II

takanaka@yamanashi.ac.jp055-273-9590

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026